This is an open-label, multi-center study. Subjects in this study will receive up to eight
(8) treatments in 11±5 weeks (6-16 weeks) interval, with the PicoWay device using the 785 nm
wavelength alone or combined with 1064 nm or 532 nm wavelengths. Subjects will return for one
follow‐up (FU) visit at the clinic at 8 weeks following the last treatment.